绿康生化(002868) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the period was ¥102,276,977.32, up 22.87% compared to the same period last year[8] - Net profit attributable to shareholders was ¥24,924,181.51, representing a 29.37% increase year-over-year[8] - Net profit for the first nine months of 2017 was ¥71,680,620.73, down 9.99% from ¥79,637,106.25 in the previous year[20] - The company expects a net profit for 2017 to range between ¥85,895,500 and ¥96,978,700, reflecting a decrease of 7.00% to an increase of 5.00% compared to 2016[22] Assets and Liabilities - Total assets increased to ¥736,929,000.84, a growth of 98.82% compared to the end of the previous year[8] - Net assets attributable to shareholders reached ¥681,435,760.35, reflecting a 151.14% increase year-over-year[8] - As of September 30, 2017, the company's cash and cash equivalents increased by 283.49% to ¥59,894,891.59 compared to December 31, 2016[18] - The company reported a significant increase in other current assets, which rose by 264,919.09% to ¥330,000,000.00, attributed to temporary idle funds from the IPO being invested in short-term wealth management products[18] - The company has reduced its short-term borrowings to zero, down from ¥30,000,000.00 in the previous period[18] Shareholder Information - The total number of shareholders at the end of the reporting period was 19,732[13] - The top ten shareholders held a combined 78.32% of the company's shares, with Shanghai Kangyi Investment holding the largest share at 30.32%[13] Earnings and Returns - Basic earnings per share remained at ¥0.21, unchanged from the previous period[8] - The weighted average return on equity was 3.73%, down 46.05% from the previous year[8] Financial Expenses and Income - Net cash flow from operating activities was ¥41,042,482.13, a decrease of 3.04% compared to the previous period[8] - The company reported non-operating income of ¥3,122,610.49, primarily from government subsidies and other income sources[9] - The company's financial expenses increased by 295.16% to ¥4,258,175.22 due to increased foreign exchange losses[18] Capital and Investments - The capital reserve increased by 902.17% to ¥375,928,310.19, primarily due to the premium from the public offering of shares[18] - The company has made significant investments in construction projects, with construction in progress increasing by 208.15% to ¥3,089,595.99[18] Compliance and Guarantees - The company has no violations regarding external guarantees during the reporting period[23]